Key result
Ischemic preconditioning reduces myocardial necrosis by activating a PKC/MAP kinase cascade that opens mitochondrial K(ATP) channels.
Answers are grounded in this paper and cite their sources.
Ischemic preconditioning is a phenomenon whereby exposure of the myocardium to a brief episode of ischemia and reperfusion markedly reduces tissue necrosis induced by a subsequent prolonged ischemia. Therefore, it is hoped that elucidation of the mechanism of preconditioning will yield therapeutic strategies capable of reducing myocardial infarction. In the rabbit, the brief period of preconditioning ischemia and reperfusion releases adenosine, bradykinin, opioids, and oxygen radicals that summate to induce the translocation and activation of protein kinase C (PKC). PKC appears to be the first element of a complex kinase cascade that is activated during the prolonged ischemia in preconditioned hearts. Current evidence indicates that PKC activates a tyrosine kinase that leads to the activation of p38 mitogen-activated protein (MAP) kinase or JNK, or possibly both. The stimulation of these stress-activated protein kinases ultimately induces the opening of mitochondrial K(ATP) channels that may be the final mediator of protection by ischemic preconditioning.
No takes yet. Share an insight, caveat, or question.
Baines et al. (1999) conducted a review in Myocardial ischemia and infarction. Ischemic preconditioning was evaluated on Myocardial tissue necrosis / protection via mitochondrial K(ATP) channel opening. Ischemic preconditioning activates a PKC-mediated tyrosine and stress-activated protein kinase (p38 MAP kinase/JNK) cascade that opens mitochondrial K(ATP) channels to reduce myocardial necrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: